ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2199

Is There an Association of Serum LDL, HDL and Total Cholesterol with the Development of Knee Osteoarthritis?

Jessica Barlow1, Xianbang Sun 2, Michael Nevitt 3, James Torner 4, Beth Lewis 5, Nirupa Matthan 6, Alice Lichtenstein 6 and David Felson 7, 1Boston University School of Medicine, Department of Rheumatology, Boston, MA, 2Boston University School of Medicine, Boston, MA, 3University of California at San Francisco, San Francisco, CA, 4University of Iowa at Iowa City, Iowa City, 5University of Alabama at Birmingham, Birmingham, AL, 6Tufts University, Boston, MA, 7Boston University School of Medicine, Department of Rheumatology, Boston

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: cholesterol and hdl, ldl, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Recent data have suggested an association between elevated serum cholesterol levels, particularly low density lipoprotein (LDL), and the development of osteoarthritis (OA).  Within the joint, circulating LDL is taken up by the synovium and oxidized, activating macrophages and leading to the release of inflammatory mediators.  Further, mice with high LDL levels have high rates of OA compared with controls. In this study, we sought to comprehensively and longitudinally evaluate whether circulating total cholesterol, LDL, and high density lipoprotein (HDL) are associated with the risk of radiographic and symptomatic knee OA.  We hypothesized that elevated levels of LDL increase the risk of developing knee OA.

Methods: We performed a nested case control study within the Multicenter Osteoarthritis study (MOST) cohort to examine the relationship between total cholesterol, LDL, and HDL and OA.  MOST is an NIH-funded longitudinal study which followed 3,026 subjects with or at risk of developing OA for a seven year period, during which knee x-rays and MRIs were obtained and knee symptoms were queried at baseline, 30, 60, and 84 months.  Baseline fasting blood samples were also drawn. We defined cases as those developing either radiographic OA (on plain film x-rays, N=283) or symptomatic OA (knee pain and radiographic OA, N=336) at follow-up.  To identify cases with  incident radiographic OA, we excluded those with prevalent radiographic OA at baseline and then followed subjects for the development of incident disease. Controls were selected randomly from those who were eligible to develop OA but did not.  We carried out an identical case and control selection procedure for incident symptomatic OA.  Additionally, we examined cartilage loss and synovitis on MRI and knee pain using the WOMAC scale.  We carried out person-specific analyses using Cox Proportional Hazards regression adjusting for age, sex, BMI and educational attainment. When analyzing pain outcomes, covariates included depressive symptoms. We tested cholesterol as a continuous measure and did sensitivity analyses examining whether commonly used thresholds for high cholesterol ( >=200mg/dl), LDL ( >=130 mg/dl) or low HDL (< =60mg/dl) increased risk.

Results: Mean age at baseline was 62 years and 55% were women.  The hazard ratio for incident radiographic OA and incident symptomatic OA according to total cholesterol, LDL, and HDL cholesterol levels as well as the mean cholesterol values showed no significant associations with OA (see table).  Additionally, we found no significant association of total cholesterol, LDL and HDL with cartilage loss, worsening synovitis or worsening knee pain. We also examined whether persons with high cholesterol, LDL or low HDL had an increased risk of OA, and did not find a significant association.

Conclusion: We did not find an association between LDL cholesterol, total cholesterol, or HDL cholesterol levels with incident osteoarthritis or other osteoarthritis outcomes. While LDL may have local deleterious effects on joint structure, elevated systemic levels do not confer risk of disease. 


Schwager.Felson.Table

Association of Cholesterol, LDL and HDL with Incident Knee OA in the MOST Study


Disclosure: J. Barlow, None; X. Sun, None; M. Nevitt, None; J. Torner, None; B. Lewis, None; N. Matthan, None; A. Lichtenstein, None; D. Felson, None.

To cite this abstract in AMA style:

Barlow J, Sun X, Nevitt M, Torner J, Lewis B, Matthan N, Lichtenstein A, Felson D. Is There an Association of Serum LDL, HDL and Total Cholesterol with the Development of Knee Osteoarthritis? [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/is-there-an-association-of-serum-ldl-hdl-and-total-cholesterol-with-the-development-of-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-there-an-association-of-serum-ldl-hdl-and-total-cholesterol-with-the-development-of-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology